3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Neoplasm Metastasis
2
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Prostate Cancer Metastatic
1
Oropharyngeal Neoplasms
1
Oligometastatic Squamous Cell Carcinoma of the Head and Neck
1
Neoplasm, Residual
1
Mouth Neoplasms
1
Mesothelioma
1
Melanoma
1
Leukemia, Myeloid, Chronic-Phase
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hodgkin Disease
1
Gallbladder Neoplasms
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Renal Cell
1
Carcinoma
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
pembrolizumab
1
cabazitaxel
1
Standard of Care
1
Radiosurgery
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Prostate Cancer Metastatic
×
pembrolizumab
×
Clear all
NCT05563558
2024-06-11
PEAPOD_FOS
Fundacion Oncosur
Phase 2
Recruiting
42 enrolled